CorNova(R) Expands Management Team with Appointment of Robert Gallahue as Chief Financi...(ecor Platinum(TM) Coronary Stent (a plat...)

Date:2/17/2009

ecor Platinum(TM) Coronary Stent (a platinum surface-modified stent), as well as manage the research and development of advanced surface modification technologies. Prior to joining CorNova(R), Sahagian founded the medical device division at Implant Sciences Corp. He earned his B.S. from the University of Lowell.

About CorNova(R)

CorNova(R) is a developer of next-generation endovascular products designed to integrate new technologies into existing products and procedures resulting in better patient outcomes without added procedure time, cost and patient risk. The company's FiberHalo(TM) stent deployment and post-dilatation balloon catheter is designed for stent deployment, lumen area measurement and post-dilatation to be performed with a single catheter. CorNova(R) is also developing a pre-dilatation form of the FiberHalo that can obtain information on arterial plaque composition allowing for better physician decision making and the Valecor Platinum(TM) Coronary Stent, a platinum surface-modified bare-metal stent, that has shown superior performance and anti-restenosis properties compared to current bare-metal stents. For more information, visit www.cornova.com.

'/>"/>

SOURCE CorNova, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related biology technology :

1. Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
2. Diplomat Specialty Pharmacy Expands National Hemophilia & IVIG Program
3. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
4. Yourway Transport Expands Biological Services
5. Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
6. Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
7. Yourway Transport Expands
8. MDV Expands Team Pursuing Advances in Personalized Medicine
9. Voler Expands Medical Device Design Capabilities
10. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
11. Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems